Preoperative Prognosticators of Safe Laparoscopic Hepatocellular Carcinoma Resection in Advanced Cirrhosis: A Propensity Score Matching Population-Based Analysis of 1,799 Western Patients

• Liver cancer often develops in patients with cirrhosis, creating a difficult surgical challenge. This study analyzed nearly 1,800 patients to identify which factors predict a safe outcome with minimally invasive liver tumor removal.
• Laparoscopic liver surgery offers advantages including less blood loss, fewer complications, and faster recovery, but not every cirrhosis patient is a good candidate.
• Dr. de la Cruz-Muñoz's involvement reflects his advanced laparoscopic expertise extending beyond bariatric procedures, sought by surgical oncology colleagues for complex cases.
• This study is part of a broader collaboration on advanced minimally invasive techniques for complex operations.
• Published in the Journal of Gastrointestinal Surgery, one of the most respected surgical journals for GI and hepatobiliary research.
• This demonstrates Dr. de la Cruz-Muñoz's expertise recognized across multiple surgical specialties.

Why This Study Was Needed

Hepatocellular carcinoma, the most common liver cancer, usually develops in a liver already scarred by cirrhosis. Operating on a cirrhotic liver is risky, and whether a laparoscopic approach is safe in advanced cirrhosis, and which patients benefit, was uncertain, particularly in Western populations.

How the Study Was Done

Using the National Cancer Database from 2010 to 2014, the team identified 1,799 patients with severe liver fibrosis who had resection of a single liver cancer. Propensity score matching paired 190 laparoscopic patients with similar open-surgery patients to compare safety and survival.

What the Study Found

• Laparoscopic and open resection had similar margins, 30- and 90-day mortality and 30-day readmissions.
• Median hospital stay was shorter after laparoscopy (6 vs 8 days).
• Median overall survival was similar: 44.2 months laparoscopic vs 39.5 months open.
• Older age, more than two comorbidities, high-grade tumors, lymph node spread and positive margins predicted worse survival.
• After adjustment, the surgical approach itself did not affect survival.

What This Means for Patients

For carefully selected patients with liver cancer and cirrhosis, laparoscopic surgery can be done safely with a shorter hospital stay. Long-term survival depends mainly on the patient’s overall health, the tumor and complete removal. Obesity-related fatty liver disease is a growing cause of cirrhosis and liver cancer; see GLP-1 medications and the liver.

Clinical Pearls

• Laparoscopic liver resection is safe in advanced cirrhosis for selected patients.
• It shortens hospital stay by about two days without compromising survival.
• Patient selection based on age, comorbidities and tumor biology drives outcomes.

Strengths and Limitations

Propensity matching in a national database reduces bias between groups. The study is retrospective, the laparoscopic group was relatively small, and liver function scores were not available in detail.

Expert Commentary

Advanced laparoscopic skills carry across operations, from bariatric surgery to the liver and pancreas. This collaboration showed that even in very high-risk patients, a minimally invasive approach can be safe when the right patient is chosen.

— Dr. Nestor de la Cruz-Muñoz

Related Research

• Does a Laparoscopic Approach to Distal Pancreatectomy for Cancer Contribute to Optimal Adjuvant Chemotherapy Utilization?